Skip to content
  • About
  • Contact
  • Contribute
  • What Physicians Say
  • My Book
  • Careers
  • Podcast
  • Speaking
KevinMD.com — Social media's leading physician voice
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • What Physicians Say
    • My Book
    • Careers
    • Podcast
    • Speaking
KevinMD.com — Social media's leading physician voice
  • All
  • Physician
  • Burnout
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
    • All
    • Physician
    • Burnout
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • About
    • Contact
    • Contribute
    • What Physicians Say
    • My Book
    • Careers
    • Podcast
    • Speaking
  • About Kevin Pho, MD, Founder of KevinMD
  • Aging and dementia: what physicians say, in their own words
  • Artificial intelligence: what physicians say, in their own words
  • Be heard on social media’s leading physician voice
  • Cancer: what physicians say, in their own words
  • Children’s health: what pediatricians say, in their own words
  • Contact Kevin
  • COVID-19: what physicians wrote as it happened
  • Custom enhanced author page pricing
  • Diabetes and obesity: what physicians say, in their own words
  • Direct primary care: what physicians say, in their own words
  • DMCA Policy
  • End of life: what physicians say, in their own words
  • Establishing, Managing, and Protecting Your Online Reputation: A Social Media Guide for Physicians and Medical Practices
  • GLP-1 drugs: what physicians say about Ozempic and its successors, in their own words
  • Heart disease: what physicians say, in their own words
  • Immigration and medicine: what physicians say about immigrant doctors and immigrant patients, in their own words
  • KevinMD influencer opportunities
  • Medical errors: what physicians say, in their own words
  • Medical ethics: what physicians say, in their own words
  • Medical malpractice: what physicians say, in their own words
  • Medical school: what students and physicians say, in their own words
  • Mental health: what psychiatrists and physicians say, in their own words
  • Nursing: what nurses and physicians say, in their own words
  • Opinion and commentary by KevinMD
  • Opioids: what physicians and pain patients say, in their own words
  • Physician burnout speakers to keynote your conference
  • Physician burnout: what physicians say, in their own words
  • Physician Coaching by KevinMD
  • Physician keynote speaker: Kevin Pho, MD
  • Physician personal finance: what physicians say about their own money, in their own words
  • Physician Speaking by KevinMD: a boutique speakers bureau
  • Physician suicide: what physicians say, in their own words
  • Physicians and administrators: what physicians say about who runs medicine, in their own words
  • Primary care physician in Nashua, NH | Kevin Pho, MD
  • Primary care: what physicians say, in their own words
  • Prior authorization: what physicians say, in their own words
  • Privacy Policy
  • Private equity and corporate medicine: what physicians say, in their own words
  • Race and medicine: what physicians say, in their own words
  • Recommended services by KevinMD
  • Residency: what residents and attendings say, in their own words
  • Scope of practice: what physicians, nurse practitioners, and PAs say, in their own words
  • Subscribe to the KevinMD enhanced author page
  • Subscribe to the newsletter
  • Surgeons and surgery: what surgeons say, in their own words
  • Take-home messages: what physicians say when asked to leave one
  • Terms of Use Agreement
  • Thank you for subscribing to KevinMD
  • Thank you for upgrading to the KevinMD enhanced author page
  • The electronic health record: what physicians say, in their own words
  • Vaccines: what physicians say, in their own words
  • Violence against health care workers: what physicians and nurses say, in their own words
  • What physicians say: the KevinMD records
  • Women in medicine: what women physicians say, in their own words
  • Women’s health: what physicians say, in their own words

The “Blue Zone” asset: This unconventional asset is found in some of the world’s healthiest portfolios

Masterworks
Physician Finance
May 7, 2023
Share
Tweet
Share

This article is sponsored by Masterworks, the art investment platform.

Physicians face a dilemma.

U.S. physicians make $237,000 a year on average. That’s 4x more than most Americans. Very impressive if you ask me. But despite high earners, they still rarely achieve early retirement.

In fact, physicians usually retire at 69 years old. That’s seven years longer than average.

While you’re most likely maxing out your IRA and allocating to traditional, safe-haven assets, the Fed’s recent interest rate policies, record-high inflation, and geopolitical conflict could cause a recession, delaying your retirement plans even longer.

Charles Schwab reports that Americans need $1,900,000 to retire. But in today’s economic environment, how can you be sure your wealth will be protected, let alone grow? Luckily, many physicians have discovered a new unconventional strategy that can potentially help you invest your way to retirement. It’s called: The Physician’s Gambit.

What is the Physician’s Gambit?

The Physician’s Gambit involves diversifying with an alternative asset class typically only found in some of the world’s HEALTHIEST portfolios. Consider it like a blue zone of assets.

One that’s supposedly so good, “Wall Street really doesn’t want you to know about it.”

Not bitcoin, not real estate, not even gold.

That may be because some alternative assets have the potential to deliver unparalleled returns. It’s no wonder some call it the best-kept secret in the investing world.

As a whole, alternative investments make up about 5% of the average investor’s portfolio. Whereas the average millionaire has roughly 26% in alternatives. Clearly, this is the difference-maker.

And while this particular alternative asset was previously off-limits to 99% of investors, physicians have gotten access to this exclusive investment thanks to a little-known law called the JOBS Act. It opened up access to a slew of new alternative investments including this one.

This may shock you, but this alternative asset is actually art. Sounds crazy, right? In reality, it couldn’t be more obvious.

ADVERTISEMENT

The “0.1% of the 0.1%” have used art to grow their fortunes and increase their status for centuries. After all, art has been the bedrock in the portfolios of America’s wealthiest individuals.

Jeff Bezos, Bill Gates, and Oprah Winfrey have built collections valued in the hundreds of millions. And before them, the Rockefellers amassed the world’s most valuable art collection ever sold—a staggering $835M.

A “powerful financial asset”

And while most people think art is nothing more than painting on a canvas, the reality is … it could be one of history’s finest investments.

According to JP Morgan, art is a “powerful financial asset.”

For example, Picasso’s painting Marie-Thérèse, originally sold for $6,800,000 in 1997. Last May, that same painting sold for $103,400,000. That’s an increase of more than 1,400% from its original value.

You don’t have to be an art expert to understand how incredible that is. And while those numbers are amazing, this is all a part of a larger trend. You don’t even need to take my word for it; look at the experts.

Citi reports that contemporary art prices appreciated by 12.9% annually on average.

That’s impressive. Especially considering the economic boom we experienced over that same period.

It’s no wonder 85% of wealth managers believe art has a place in their wealth management offerings.

Art as an inflation hedge

We’re currently seeing inflation around 5% — still well above the Federal Reserve’s 2% target.

Traditionally, people turned to traditional assets like gold or real estate to keep inflation from eroding their wealth.

But Bank of America’s chief investment strategist believes art could offer a high level of protection from inflation.

As you can see below, contemporary art’s appreciation jumps to 13.5% when inflation is above 3%.

Resilient in downturns

Historically, fine art does well during times of economic uncertainty. According to Citi, art has one of the lowest correlations to the stock market. This makes art a potentially useful hedge against market volatility.

In other words, when stocks dip, your art investments may not.

Case in point: During the first seven months of 2020, contemporary art outpaced every other asset class, including stocks, real estate, and even hedge funds.

This explains why the demand for art jumps during recessions. When stocks plummeted in 2008, money flowing into masterpiece art increased by nearly 4x.

And today, even with the whispers of a recession circulating around the country, an expert told the Wall Street Journal, “the art market is carrying on as normal.” In fact, Paul Allen’s collection recently sold for a record-breaking $1.5 billion.

Once you take all of this into account, you understand why many billionaires allocate 10 to 30% of their portfolios to art.

Diversifying your portfolio with art

With art, like other asset classes, the best investments are often the most expensive. Because most paintings that tend to have the biggest returns have price tags north of $3 million, you’d need generational wealth to add art to your portfolio.

And once you buy the entire painting, you’d actually have to store the darn thing.

The workaround? There’s a little-known — and incredibly smart way — for everyday people like you and me to invest in contemporary art. One that lets you do so for a fraction of the cost.

Masterworks, the alternative art investment platform, destroyed this high-cost barrier to entry. They’ve made investing in this $1.7 trillion asset class simple. Instead of buying entire paintings, you can invest in shares of multiple paintings.

How it works

Masterworks has a world-class research team that does extensive data analysis to find quality paintings for investors. Experts have compared their database to a “Bloomberg terminal for art.” They’ve figured out that some works have more predictable price appreciation.

When they’ve identified a work of art that’s likely to appreciate, they buy it and qualify it with the SEC. After that, they can issue shares on their platform.

You can then buy an equity stake in that painting. Masterworks holds the piece until it appreciates, and when they sell, you get a prorated portion of the profit. And you have the option to sell your shares on their secondary market at any time if you’d like as well.

It’s that simple.

Since 2019, Masterworks has resold 13 offerings, with the last few delivering 10%, 14%, and 35% in net annualized gains to investors. Past performance doesn’t guarantee future results, but this is still quite impressive so far.

So, you’re probably wondering, why am I only hearing about this now?

To date, Masterworks has securitized over $700 million dollars worth of art, and over 675,000 investors have signed up. This year alone, they’re planning to reach over $1B worth of art on their platform.

And have been featured in the Wall Street Journal, Bloomberg Forbes, and other major publications.

Most people don’t get access to this platform right away. New clients are put on a waitlist, but KevinMD readers who use our link skip straight to browsing the current offerings.

All you have to do is click here to skip the waitlist and invest in multimillion-dollar paintings.

P.S. Masterworks has launched a new fund-like product called the “diversified art portfolio” or the “DAP” for short. The DAP lets you invest in a pool of 60 to 80 paintings that their team handpicks for you. But you have to be an accredited investor to access this feature.

This article is provided for informational and educational purposes only. It is not intended to be investment advice and should not form the basis of an investment decision.

Masterworks is the first platform for buying and selling shares representing an investment in iconic artworks. Build a diversified portfolio of expertly-vetted works curated by our industry-leading research team. Please review Masterworks’ disclosures.

Prev

Rebuilding trust in the patient-physician relationship in the digital health era [PODCAST]

May 7, 2023 Kevin 0
…
Next

Revolutionize your practice: the value-based care model that reduces physician burnout

May 8, 2023 Kevin 4
…

Tagged as: Practice Management

< Previous Post
Rebuilding trust in the patient-physician relationship in the digital health era [PODCAST]
Next Post >
Revolutionize your practice: the value-based care model that reduces physician burnout

 

ADVERTISEMENT

More by Masterworks

  • Where to invest $25K in 2023 according to experts

    Masterworks
  • The “Physician’s Gambit”: an unconventional, but effective wealth preservation play for 2022

    Masterworks
  • The estimated $1.7 trillion legacy asset Jeff Bezos loves. (Physicians can easily diversify their portfolio with this.)

    Masterworks

Related Posts

  • A paradigm shift in acute pain assessment and management

    Myles Gart, MD
  • The slippery slope of utilization management

    Sneha Tella, MD
  • Medication management and how consultant pharmacists can help

    Michael R. McGuire
  • It’s time to learn the basics of financial management in medical school

    Aashish Shah
  • Think twice before prescribing opioids as a first-line treatment for pain

    Gary Call, MD
  • The promises and limits of a fentanyl vaccine

    Julie Craig, MD

More in Physician Finance

  • Paid for twice

    Physicians paid for G2211 twice. Most never bill it.

    Michael Duben, MD
  • Why physician financial freedom matters more than salary

    Arthur Lazarus, MD, MBA
  • Charitable giving for physicians: 7 strategies for 2026

    Logan Foltz, MD
  • The sweet spot before physician financial independence

    Stanley Liu, MD
  • Negotiating physician compensation works better in groups

    Contract Diagnostics
  • How doctors lose money investing: 6 failure modes

    Harsha Moole, MD

More in Sponsored

  • Making AI work for physicians [PODCAST]

    The Podcast by KevinMD
  • Taking a leap of faith in my career was the best thing for my patients and me

    CenterWell Senior Primary Care and Conviva Senior Primary Care
  • The home gym built for doctors with no time

    Tonal Team
  • 2026 cholesterol guidelines: LDL goals, Lp(a), and coronary calcium scoring [PODCAST]

    The Podcast by KevinMD
  • Why early detection matters: Transforming lung cancer care [PODCAST]

    The Podcast by KevinMD
  • What HCPs across the country are saying about policy and emerging research and why your voice matters

    InCrowd
  • Most Popular

  • Past Week

    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • The conflict of interest that discloses as nothing

      Martha Rosenberg | Medications
    • Surgical judgment: the skill no one sees from the gallery

      Mustafa Kemal Çalık, MD | Physician
    • Why haven’t ambient AI scribes boosted productivity?

      Karan Kanwar | Health Technology
    • 3 reforms to counter wellness influencers in practice

      Farid Sabet-Sharghi, MD | Physician
    • Physician well-being is not an individual problem

      Heather Buckley | Conditions and Diseases
  • Past 6 Months

    • Why CDC opioid guidelines get the overdose data wrong

      Richard A. Lawhern, PhD | Conditions and Diseases
    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Sensory processing in autism and the brain’s volume control

      Josette Pelatan, PhD | Conditions and Diseases
    • What maternity care deserts cost a town

      Manisha Kaliaperumal | Health Policy
    • Why medicine needs a national physician license now

      Vaishali Popat, MD, MPH | Physician
    • A cold cost $945. The cost of primary care is broken.

      Susan Newman, MD | Physician
  • Recent Posts

    • 3 reforms to counter wellness influencers in practice

      Farid Sabet-Sharghi, MD | Physician
    • Shift work and circadian rhythms shape the 24/7 workplace

      Deepak Gupta, MD | Conditions and Diseases
    • Paid for twice

      Physicians paid for G2211 twice. Most never bill it.

      Michael Duben, MD | Physician Finance
    • The next child

      Medicaid managed care and the case for mutual stewardship

      Steven Merahn, MD | Health Policy
    • Choosing a limb lengthening surgeon requires accountability

      Hrayr Basmajian, MD | Physician
    • Cited but never checked

      Why AI crisis advice may fail families facing psychosis

      Nicole Drapeau Gillen | Health Technology

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • The conflict of interest that discloses as nothing

      Martha Rosenberg | Medications
    • Surgical judgment: the skill no one sees from the gallery

      Mustafa Kemal Çalık, MD | Physician
    • Why haven’t ambient AI scribes boosted productivity?

      Karan Kanwar | Health Technology
    • 3 reforms to counter wellness influencers in practice

      Farid Sabet-Sharghi, MD | Physician
    • Physician well-being is not an individual problem

      Heather Buckley | Conditions and Diseases
  • Past 6 Months

    • Why CDC opioid guidelines get the overdose data wrong

      Richard A. Lawhern, PhD | Conditions and Diseases
    • Retirement isn’t the end of medicine, it’s a second act [PODCAST]

      The Podcast by KevinMD | Podcast
    • Sensory processing in autism and the brain’s volume control

      Josette Pelatan, PhD | Conditions and Diseases
    • What maternity care deserts cost a town

      Manisha Kaliaperumal | Health Policy
    • Why medicine needs a national physician license now

      Vaishali Popat, MD, MPH | Physician
    • A cold cost $945. The cost of primary care is broken.

      Susan Newman, MD | Physician
  • Recent Posts

    • 3 reforms to counter wellness influencers in practice

      Farid Sabet-Sharghi, MD | Physician
    • Shift work and circadian rhythms shape the 24/7 workplace

      Deepak Gupta, MD | Conditions and Diseases
    • Paid for twice

      Physicians paid for G2211 twice. Most never bill it.

      Michael Duben, MD | Physician Finance
    • The next child

      Medicaid managed care and the case for mutual stewardship

      Steven Merahn, MD | Health Policy
    • Choosing a limb lengthening surgeon requires accountability

      Hrayr Basmajian, MD | Physician
    • Cited but never checked

      Why AI crisis advice may fail families facing psychosis

      Nicole Drapeau Gillen | Health Technology

Copyright © 2026 KevinMD.com | Powered by Astra WordPress Theme

  • Terms of Use Agreement
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...